Wednesday, December 28, 2005


FDA gives Fast Track status to Vertex s Hepatitis C treatment (Hep C)


FDA gives Fast Track status to Vertex s Hepatitis C treatment
Mass High Tech - The U.S. Food and Drug Administration has granted Fast Track designation to VX-950, an investigational oral hepatitis C virus (HCV) treatment being developed by Vertex Pharmaceuticals Inc. According to Vertex officials, the FDA granted the Fast Track

Saliva Hep C Test Developed
Red Herring - Israeli researchers have developed a test for the hepatitis C virus based on a sample of saliva, suggesting mass screening for the liver disease may be possible in parts of the developing world where blood testing is less feasible. The aim of the

South Africa: Heading for a Bumper Year
AllAfrica.com - THE South African market for commercial vehicles of more than 3500kg Gross Vehicle Mass (GVM) surged ahead during November to record the second highest single month's sales return in the history of this market. The total sales of 2733 units reported